Review Article| Volume 50, ISSUE 1, P17-25, March 2023

Inclusion of Pregnant and Lactating People in Clinical Research

Lessons Learned and Opportunities


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Obstetrics and Gynecology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Research, N.C.f.t.P.o.H.S.o.B.a.B
        Research on the fetus.
        U.S Department of Health, Education, and Welfare, 1975
        • Byrne J.J.
        • Saucedo A.M.
        • Spong C.Y.
        Task force on research specific to pregnant and lactating women.
        Semin Perinatol. 2020; 44: 151226
        • Mitchell A.A.
        • Gilboa S.M.
        • Werler M.M.
        • et al.
        Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.
        Am J Obstet Gynecol. 2011; 205: 51.e1-51.e8
        • Lo W.Y.
        • Friedman J.M.
        Teratogenicity of recently introduced medications in human pregnancy.
        Obstet Gynecol. 2002; 100: 465-473
        • Kim J.H.
        • Scialli A.R.
        Thalidomide: the tragedy of birth defects and the effective treatment of disease.
        Toxicol Sci. 2011; 122: 1-6
        • Liu K.A.
        • Mager N.A.
        Women's involvement in clinical trials: historical perspective and future implications.
        Pharm Pract (Granada). 2016; 14: 708
      1. Health, N.I.o. History of Women’s Participation in Clinical Research. NIH Inclusion Outreach Toolkit: How to Engage, Recruit, and Retain Women in Clinical Research 2022.
        Date: 2022
        Date accessed: July 12, 2022
        • Merkatz R.B.
        Inclusion of women in clinical trials: a historical overview of scientific, ethical, and legal issues.
        J Obstet Gynecol Neonatal Nurs. 1998; 27: 78-84
        • Evelyn B.
        • Toigo T.
        • Banks D.
        • et al.
        Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999.
        J Natl Med Assoc. 2001; 93: 18s-24s
        • Blehar M.C.
        • Spong C.
        • Grady C.
        • et al.
        Enrolling pregnant women: issues in clinical research.
        Womens Health Issues. 2013; 23: e39-e45
        • Ren Z.
        • Bremer A.A.
        • Pawlyk A.C.
        Drug development research in pregnant and lactating women.
        Am J Obstet Gynecol. 2021; 225: 33-42
        • Parisi M.A.
        • Spong C.Y.
        • Zajicek A.
        • et al.
        We don’t know what we don’t study: the case for research on medication effects in pregnancy.
        Am J Med Genet C Semin Med Genet. 2011; 157c: 247-250
        • Spong C.Y.
        • Bianchi D.W.
        Improving public health requires inclusion of underrepresented populations in research.
        JAMA. 2018; 319: 337-338
        • Nooney J.
        • Thor S.
        • de Vries C.
        • et al.
        Assuring access to safe medicines in pregnancy and breastfeeding.
        Clin Pharmacol Ther. 2021; 110: 941-945
        • Waggoner M.R.
        • Lyerly A.D.
        Clinical trials in pregnancy and the "shadows of thalidomide": revisiting the legacy of Frances Kelsey.
        Contemp Clin Trials. 2022; 119: 106806
        • Health N.I.o.
        Task force on research specific to pregnant women and lactating women.
        PRGLAC, 2018
        • Health N.I.o.
        TASK force on research specific to pregnant women and lactating women- report implementation plan.
        PRGLAC, 2020
        • Thiele L.
        • Thompson J.
        • Pruszynski J.
        • et al.
        Gaps in evidence-based medicine: underrepresented populations still excluded from research trials following 2018 recommendations from the Health and Human Services Task Force on Research Specific to Pregnant Women and Lactating Women.
        Am J Obstet Gynecol. 2022;
        • Byrne J.J.
        • Saucedo A.M.
        • Spong C.Y.
        Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule.
        JAMA Netw Open. 2020; 3: e2015094
        • Brucker M.C.
        • King T.L.
        The 2015 US food and drug administration pregnancy and lactation labeling rule.
        J Midwifery Women's Health. 2017; 62: 308-316
        • Freeman M.P.
        • Farchione T.
        • Yao L.
        • et al.
        Psychiatric medications and reproductive safety: scientific and clinical perspectives pertaining to the US FDA pregnancy and lactation labeling rule.
        J Clin Psychiatry. 2018; 79
      2. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
        Fed Regist. 2014; 79: 72063-72103
        • Dinatale M.
        • Roca C.
        • Sahin L.
        • et al.
        The importance of clinical research in pregnant women to inform prescription drug labeling.
        J Clin Pharmacol. 2020; 60: S18-S25
        • Harris J.B.
        • Holmes A.P.
        • Eiland L.S.
        The Influence of the food and drug administration pregnancy and lactation labeling rule on drug information resources.
        Ann Pharmacother. 2021; 55: 459-465
        • Namazy J.
        • Chambers C.
        • Sahin L.
        • et al.
        Clinicians’ perspective of the new pregnancy and lactation labeling rule (PLLR): results from an AAAAI/FDA survey.
        J Allergy Clin Immunol Pract. 2020; 8: 1947-1952
        • Alem G.
        • Awuonda M.
        • Haastrup D.
        • et al.
        Evaluation of knowledge of the new Pregnancy and Lactation Labeling Rule among pharmacists and physicians.
        J Am Pharm Assoc (2003). 2022; 62: 427-431
        • Rubin R.
        Pregnant people’s paradox—excluded from vaccine trials despite having a higher risk of COVID-19 complications.
        JAMA. 2021; 325: 1027-1028
        • Adhikari E.H.
        • Spong C.Y.
        Pregnancy is not a disability: including pregnant healthcare workers in COVID-19 vaccine mandates.
        Am J Obstet Gynecol. 2022; 226: 757-759